Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to recover and partially adapted to pandemic restrictions. The research and development of vaccines has made breakthrough progress, and many governments have also issued various policies to stimulate economic recovery, particularly in the United States, is likely to provide a strong boost to economic activity but prospects for sustainable growth vary widely between countries and sectors. Although the global economy is recovering from the great depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged period. The pandemic has exacerbated the risks associated with the decade-long wave of global debt accumulation. It is also likely to steepen the long-expected slowdown in potential growth over the next decade.
By Market Players:
Abbott Laboratories
Pfizer Inc.
Genentech Inc.
Novartis AG
Biogen Idec
AbbVie Inc.
F. Hoffmann-La Roche AG
Bristol-Myers Squibb
Eisai Inc.
Takeda Pharmaceuticals Ltd.
Alnylam Pharmaceuticals
Bayer AG
GlaxoSmithKline
By Type
Syringe
Wearable injector
Automatic injector
Implants
By Application
Hospital pharmacies
Retail pharmacies
Drug stores
Online pharmacies
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Subcutaneous Biologics 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Subcutaneous Biologics Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Subcutaneous Biologics Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Subcutaneous Biologics market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Chapter 1 Subcutaneous Biologics Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Subcutaneous Biologics
1.3 Subcutaneous Biologics Market Scope and Market Size Estimation
1.3.1 Global Subcutaneous Biologics Value and Growth Rate from 2022-2027
1.4 Market Segmentation
1.4.1 Types of Subcutaneous Biologics
1.4.2 Applications of Subcutaneous Biologics
1.4.3 Overview of Global Subcutaneous Biologics Market
1.5 COVID-19 Outbreak: Subcutaneous Biologics Industry Impact
Chapter 2 Industry Chain Analysis
2.1 Upstream Raw Material Suppliers of Subcutaneous Biologics Analysis
2.2 Major Players of Subcutaneous Biologics
2.2.1 Major Players Manufacturing Base and Market Share of Subcutaneous Biologics in 2021
2.3 Subcutaneous Biologics Manufacturing Cost Structure Analysis
2.3.1 Manufacturing Cost Structure of Subcutaneous Biologics
2.3.2 Labor Cost of Subcutaneous Biologics
2.4 Market Channel Analysis of Subcutaneous Biologics
2.5 Value Chain Status Under COVID-19
Chapter 3 Global Subcutaneous Biologics Competition by Types, Applications, and Top Regions and Countries
3.1 Global Subcutaneous Biologics (Volume and Value) by Type
3.1.1 Global Subcutaneous Biologics Consumption and Market Share by Type (2016-2021)
3.1.2 Global Subcutaneous Biologics Revenue and Market Share by Type (2016-2021)
3.2 Global Subcutaneous Biologics (Volume and Value) by Application
3.2.1 Global Subcutaneous Biologics Consumption and Market Share by Application (2016-2021)
3.2.2 Global Subcutaneous Biologics Revenue and Market Share by Application (2016-2021)
3.3 Global Subcutaneous Biologics (Volume and Value) by Regions
3.3.1 Global Subcutaneous Biologics Consumption and Market Share by Regions (2016-2021)
3.3.2 Global Subcutaneous Biologics Revenue and Market Share by Regions (2016-2021)
Chapter 4 Global Subcutaneous Biologics Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Subcutaneous Biologics Consumption by Regions (2016-2021)
4.2 North America Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
4.10 South America Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Subcutaneous Biologics Market Analysis
5.1 North America Subcutaneous Biologics Consumption and Value Analysis
5.1.1 North America Subcutaneous Biologics Market Under COVID-19
5.2 North America Subcutaneous Biologics Consumption Volume by Types
5.3 North America Subcutaneous Biologics Consumption Structure by Application
5.4 North America Subcutaneous Biologics Consumption by Top Countries
5.4.1 United States Subcutaneous Biologics Consumption Volume from 2016 to 2021
5.4.2 Canada Subcutaneous Biologics Consumption Volume from 2016 to 2021
5.4.3 Mexico Subcutaneous Biologics Consumption Volume from 2016 to 2021
Chapter 6 East Asia Subcutaneous Biologics Market Analysis
6.1 East Asia Subcutaneous Biologics Consumption and Value Analysis
6.1.1 East Asia Subcutaneous Biologics Market Under COVID-19
6.2 East Asia Subcutaneous Biologics Consumption Volume by Types
6.3 East Asia Subcutaneous Biologics Consumption Structure by Application
6.4 East Asia Subcutaneous Biologics Consumption by Top Countries
6.4.1 China Subcutaneous Biologics Consumption Volume from 2016 to 2021
6.4.2 Japan Subcutaneous Biologics Consumption Volume from 2016 to 2021
6.4.3 South Korea Subcutaneous Biologics Consumption Volume from 2016 to 2021
Chapter 7 Europe Subcutaneous Biologics Market Analysis
7.1 Europe Subcutaneous Biologics Consumption and Value Analysis
7.1.1 Europe Subcutaneous Biologics Market Under COVID-19
7.2 Europe Subcutaneous Biologics Consumption Volume by Types
7.3 Europe Subcutaneous Biologics Consumption Structure by Application
7.4 Europe Subcutaneous Biologics Consumption by Top Countries
7.4.1 Germany Subcutaneous Biologics Consumption Volume from 2016 to 2021
7.4.2 UK Subcutaneous Biologics Consumption Volume from 2016 to 2021
7.4.3 France Subcutaneous Biologics Consumption Volume from 2016 to 2021
7.4.4 Italy Subcutaneous Biologics Consumption Volume from 2016 to 2021
7.4.5 Russia Subcutaneous Biologics Consumption Volume from 2016 to 2021
7.4.6 Spain Subcutaneous Biologics Consumption Volume from 2016 to 2021
7.4.7 Netherlands Subcutaneous Biologics Consumption Volume from 2016 to 2021
7.4.8 Switzerland Subcutaneous Biologics Consumption Volume from 2016 to 2021
7.4.9 Poland Subcutaneous Biologics Consumption Volume from 2016 to 2021
Chapter 8 South Asia Subcutaneous Biologics Market Analysis
8.1 South Asia Subcutaneous Biologics Consumption and Value Analysis
8.1.1 South Asia Subcutaneous Biologics Market Under COVID-19
8.2 South Asia Subcutaneous Biologics Consumption Volume by Types
8.3 South Asia Subcutaneous Biologics Consumption Structure by Application
8.4 South Asia Subcutaneous Biologics Consumption by Top Countries
8.4.1 India Subcutaneous Biologics Consumption Volume from 2016 to 2021
8.4.2 Pakistan Subcutaneous Biologics Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Subcutaneous Biologics Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Subcutaneous Biologics Market Analysis
9.1 Southeast Asia Subcutaneous Biologics Consumption and Value Analysis
9.1.1 Southeast Asia Subcutaneous Biologics Market Under COVID-19
9.2 Southeast Asia Subcutaneous Biologics Consumption Volume by Types
9.3 Southeast Asia Subcutaneous Biologics Consumption Structure by Application
9.4 Southeast Asia Subcutaneous Biologics Consumption by Top Countries
9.4.1 Indonesia Subcutaneous Biologics Consumption Volume from 2016 to 2021
9.4.2 Thailand Subcutaneous Biologics Consumption Volume from 2016 to 2021
9.4.3 Singapore Subcutaneous Biologics Consumption Volume from 2016 to 2021
9.4.4 Malaysia Subcutaneous Biologics Consumption Volume from 2016 to 2021
9.4.5 Philippines Subcutaneous Biologics Consumption Volume from 2016 to 2021
9.4.6 Vietnam Subcutaneous Biologics Consumption Volume from 2016 to 2021
9.4.7 Myanmar Subcutaneous Biologics Consumption Volume from 2016 to 2021
Chapter 10 Middle East Subcutaneous Biologics Market Analysis
10.1 Middle East Subcutaneous Biologics Consumption and Value Analysis
10.1.1 Middle East Subcutaneous Biologics Market Under COVID-19
10.2 Middle East Subcutaneous Biologics Consumption Volume by Types
10.3 Middle East Subcutaneous Biologics Consumption Structure by Application
10.4 Middle East Subcutaneous Biologics Consumption by Top Countries
10.4.1 Turkey Subcutaneous Biologics Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Subcutaneous Biologics Consumption Volume from 2016 to 2021
10.4.3 Iran Subcutaneous Biologics Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Subcutaneous Biologics Consumption Volume from 2016 to 2021
10.4.5 Israel Subcutaneous Biologics Consumption Volume from 2016 to 2021
10.4.6 Iraq Subcutaneous Biologics Consumption Volume from 2016 to 2021
10.4.7 Qatar Subcutaneous Biologics Consumption Volume from 2016 to 2021
10.4.8 Kuwait Subcutaneous Biologics Consumption Volume from 2016 to 2021
10.4.9 Oman Subcutaneous Biologics Consumption Volume from 2016 to 2021
Chapter 11 Africa Subcutaneous Biologics Market Analysis
11.1 Africa Subcutaneous Biologics Consumption and Value Analysis
11.1.1 Africa Subcutaneous Biologics Market Under COVID-19
11.2 Africa Subcutaneous Biologics Consumption Volume by Types
11.3 Africa Subcutaneous Biologics Consumption Structure by Application
11.4 Africa Subcutaneous Biologics Consumption by Top Countries
11.4.1 Nigeria Subcutaneous Biologics Consumption Volume from 2016 to 2021
11.4.2 South Africa Subcutaneous Biologics Consumption Volume from 2016 to 2021
11.4.3 Egypt Subcutaneous Biologics Consumption Volume from 2016 to 2021
11.4.4 Algeria Subcutaneous Biologics Consumption Volume from 2016 to 2021
11.4.5 Morocco Subcutaneous Biologics Consumption Volume from 2016 to 2021
Chapter 12 Oceania Subcutaneous Biologics Market Analysis
12.1 Oceania Subcutaneous Biologics Consumption and Value Analysis
12.2 Oceania Subcutaneous Biologics Consumption Volume by Types
12.3 Oceania Subcutaneous Biologics Consumption Structure by Application
12.4 Oceania Subcutaneous Biologics Consumption by Top Countries
12.4.1 Australia Subcutaneous Biologics Consumption Volume from 2016 to 2021
12.4.2 New Zealand Subcutaneous Biologics Consumption Volume from 2016 to 2021
Chapter 13 South America Subcutaneous Biologics Market Analysis
13.1 South America Subcutaneous Biologics Consumption and Value Analysis
13.1.1 South America Subcutaneous Biologics Market Under COVID-19
13.2 South America Subcutaneous Biologics Consumption Volume by Types
13.3 South America Subcutaneous Biologics Consumption Structure by Application
13.4 South America Subcutaneous Biologics Consumption Volume by Major Countries
13.4.1 Brazil Subcutaneous Biologics Consumption Volume from 2016 to 2021
13.4.2 Argentina Subcutaneous Biologics Consumption Volume from 2016 to 2021
13.4.3 Columbia Subcutaneous Biologics Consumption Volume from 2016 to 2021
13.4.4 Chile Subcutaneous Biologics Consumption Volume from 2016 to 2021
13.4.5 Venezuela Subcutaneous Biologics Consumption Volume from 2016 to 2021
13.4.6 Peru Subcutaneous Biologics Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Subcutaneous Biologics Consumption Volume from 2016 to 2021
13.4.8 Ecuador Subcutaneous Biologics Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Subcutaneous Biologics Business
14.1 Abbott Laboratories
14.1.1 Abbott Laboratories Company Profile
14.1.2 Abbott Laboratories Subcutaneous Biologics Product Specification
14.1.3 Abbott Laboratories Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Pfizer Inc.
14.2.1 Pfizer Inc. Company Profile
14.2.2 Pfizer Inc. Subcutaneous Biologics Product Specification
14.2.3 Pfizer Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Genentech Inc.
14.3.1 Genentech Inc. Company Profile
14.3.2 Genentech Inc. Subcutaneous Biologics Product Specification
14.3.3 Genentech Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Novartis AG
14.4.1 Novartis AG Company Profile
14.4.2 Novartis AG Subcutaneous Biologics Product Specification
14.4.3 Novartis AG Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Biogen Idec
14.5.1 Biogen Idec Company Profile
14.5.2 Biogen Idec Subcutaneous Biologics Product Specification
14.5.3 Biogen Idec Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 AbbVie Inc.
14.6.1 AbbVie Inc. Company Profile
14.6.2 AbbVie Inc. Subcutaneous Biologics Product Specification
14.6.3 AbbVie Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 F. Hoffmann-La Roche AG
14.7.1 F. Hoffmann-La Roche AG Company Profile
14.7.2 F. Hoffmann-La Roche AG Subcutaneous Biologics Product Specification
14.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Bristol-Myers Squibb
14.8.1 Bristol-Myers Squibb Company Profile
14.8.2 Bristol-Myers Squibb Subcutaneous Biologics Product Specification
14.8.3 Bristol-Myers Squibb Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Eisai Inc.
14.9.1 Eisai Inc. Company Profile
14.9.2 Eisai Inc. Subcutaneous Biologics Product Specification
14.9.3 Eisai Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Takeda Pharmaceuticals Ltd.
14.10.1 Takeda Pharmaceuticals Ltd. Company Profile
14.10.2 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product Specification
14.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Alnylam Pharmaceuticals
14.11.1 Alnylam Pharmaceuticals Company Profile
14.11.2 Alnylam Pharmaceuticals Subcutaneous Biologics Product Specification
14.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Bayer AG
14.12.1 Bayer AG Company Profile
14.12.2 Bayer AG Subcutaneous Biologics Product Specification
14.12.3 Bayer AG Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 GlaxoSmithKline
14.13.1 GlaxoSmithKline Company Profile
14.13.2 GlaxoSmithKline Subcutaneous Biologics Product Specification
14.13.3 GlaxoSmithKline Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Subcutaneous Biologics Market Forecast (2022-2027)
15.1 Global Subcutaneous Biologics Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Subcutaneous Biologics Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
15.2 Global Subcutaneous Biologics Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Subcutaneous Biologics Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Subcutaneous Biologics Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Subcutaneous Biologics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Subcutaneous Biologics Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Subcutaneous Biologics Consumption Forecast by Type (2022-2027)
15.3.2 Global Subcutaneous Biologics Revenue Forecast by Type (2022-2027)
15.3.3 Global Subcutaneous Biologics Price Forecast by Type (2022-2027)
15.4 Global Subcutaneous Biologics Consumption Volume Forecast by Application (2022-2027)
15.5 Subcutaneous Biologics Market Forecast Under COVID-19
Chapter 16 New Project Feasibility Analysis
16.1 Industry Barriers and New Entrants SWOT Analysis
16.2 Analysis and Suggestions on New Project Investment
Chapter 17 Research Finding and Conclusion
Chapter 18 Appendix
18.1 Methodology
18.2 Research Data Source
18.2.1 Secondary Data
18.2.2 Primary Data
18.2.3 Market Size Estimation
18.2.4 Legal Disclaimer
Figure Product Picture of Subcutaneous Biologics
Figure Global Subcutaneous Biologics Value ($) and Growth Rate from 2022-2027
Table Global Subcutaneous Biologics Value ($) Segment by Type from 2016-2021
Figure Global Subcutaneous Biologics Market Share by Types in 2021
Figure Subcutaneous Biologics Syringe Picture
Figure Subcutaneous Biologics Wearable injector Picture
Figure Subcutaneous Biologics Automatic injector Picture
Figure Subcutaneous Biologics Implants Picture
Table Global Subcutaneous Biologics Value ($) Segment by Applications from 2016-2021
Figure Global Subcutaneous Biologics Market Share by Applications in 2019
Figure Hospital pharmacies Picture
Figure Retail pharmacies Picture
Figure Drug stores Picture
Figure Online pharmacies Picture
Figure Industry Chain Analysis of Subcutaneous Biologics
Table Major Players Manufacturing Base of Subcutaneous Biologics in 2021
Table Major Players Sales Value Market Share of Subcutaneous Biologics 2016-2021
Figure Manufacturing Cost Structure of Subcutaneous Biologics
Figure Channel Status of Subcutaneous Biologics
Table Global Subcutaneous Biologics Consumption and Market Share by Type (2016-2021)
Table Global Subcutaneous Biologics Revenue and Market Share by Type (2016-2021)
Table Global Subcutaneous Biologics Consumption and Market Share by Application (2016-2021)
Table Global Subcutaneous Biologics Revenue and Market Share by Application (2016-2021)
Table Global Subcutaneous Biologics Consumption and Market Share by Regions (2016-2021)
Table Global Subcutaneous Biologics Revenue and Market Share by Regions (2016-2021)
Table Global Subcutaneous Biologics Consumption by Regions (2016-2021)
Figure Global Subcutaneous Biologics Consumption Share by Regions (2016-2021)
Table North America Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
Table East Asia Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
Table Europe Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
Table South Asia Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
Table Southeast Asia Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
Table Middle East Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
Table Africa Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
Table Oceania Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
Table South America Subcutaneous Biologics Sales, Consumption, Export, Import (2016-2021)
Figure North America Subcutaneous Biologics Consumption and Growth Rate (2016-2021)
Figure North America Subcutaneous Biologics Revenue and Growth Rate (2016-2021)
Table North America Subcutaneous Biologics Sales Price Analysis (2016-2021)
Table North America Subcutaneous Biologics Consumption Volume by Types
Table North America Subcutaneous Biologics Consumption Structure by Application
Table North America Subcutaneous Biologics Consumption by Top Countries
Figure United States Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Canada Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Mexico Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure East Asia Subcutaneous Biologics Consumption and Growth Rate (2016-2021)
Figure East Asia Subcutaneous Biologics Revenue and Growth Rate (2016-2021)
Table East Asia Subcutaneous Biologics Sales Price Analysis (2016-2021)
Table East Asia Subcutaneous Biologics Consumption Volume by Types
Table East Asia Subcutaneous Biologics Consumption Structure by Application
Table East Asia Subcutaneous Biologics Consumption by Top Countries
Figure China Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Japan Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure South Korea Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Europe Subcutaneous Biologics Consumption and Growth Rate (2016-2021)
Figure Europe Subcutaneous Biologics Revenue and Growth Rate (2016-2021)
Table Europe Subcutaneous Biologics Sales Price Analysis (2016-2021)
Table Europe Subcutaneous Biologics Consumption Volume by Types
Table Europe Subcutaneous Biologics Consumption Structure by Application
Table Europe Subcutaneous Biologics Consumption by Top Countries
Figure Germany Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure UK Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure France Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Italy Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Russia Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Spain Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Netherlands Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Switzerland Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Poland Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure South Asia Subcutaneous Biologics Consumption and Growth Rate (2016-2021)
Figure South Asia Subcutaneous Biologics Revenue and Growth Rate (2016-2021)
Table South Asia Subcutaneous Biologics Sales Price Analysis (2016-2021)
Table South Asia Subcutaneous Biologics Consumption Volume by Types
Table South Asia Subcutaneous Biologics Consumption Structure by Application
Table South Asia Subcutaneous Biologics Consumption by Top Countries
Figure India Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Pakistan Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Bangladesh Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Southeast Asia Subcutaneous Biologics Consumption and Growth Rate (2016-2021)
Figure Southeast Asia Subcutaneous Biologics Revenue and Growth Rate (2016-2021)
Table Southeast Asia Subcutaneous Biologics Sales Price Analysis (2016-2021)
Table Southeast Asia Subcutaneous Biologics Consumption Volume by Types
Table Southeast Asia Subcutaneous Biologics Consumption Structure by Application
Table Southeast Asia Subcutaneous Biologics Consumption by Top Countries
Figure Indonesia Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Thailand Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Singapore Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Malaysia Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Philippines Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Vietnam Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Myanmar Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Middle East Subcutaneous Biologics Consumption and Growth Rate (2016-2021)
Figure Middle East Subcutaneous Biologics Revenue and Growth Rate (2016-2021)
Table Middle East Subcutaneous Biologics Sales Price Analysis (2016-2021)
Table Middle East Subcutaneous Biologics Consumption Volume by Types
Table Middle East Subcutaneous Biologics Consumption Structure by Application
Table Middle East Subcutaneous Biologics Consumption by Top Countries
Figure Turkey Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Saudi Arabia Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Iran Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure United Arab Emirates Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Israel Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Iraq Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Qatar Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Kuwait Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Oman Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Africa Subcutaneous Biologics Consumption and Growth Rate (2016-2021)
Figure Africa Subcutaneous Biologics Revenue and Growth Rate (2016-2021)
Table Africa Subcutaneous Biologics Sales Price Analysis (2016-2021)
Table Africa Subcutaneous Biologics Consumption Volume by Types
Table Africa Subcutaneous Biologics Consumption Structure by Application
Table Africa Subcutaneous Biologics Consumption by Top Countries
Figure Nigeria Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure South Africa Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Egypt Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Algeria Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Algeria Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Oceania Subcutaneous Biologics Consumption and Growth Rate (2016-2021)
Figure Oceania Subcutaneous Biologics Revenue and Growth Rate (2016-2021)
Table Oceania Subcutaneous Biologics Sales Price Analysis (2016-2021)
Table Oceania Subcutaneous Biologics Consumption Volume by Types
Table Oceania Subcutaneous Biologics Consumption Structure by Application
Table Oceania Subcutaneous Biologics Consumption by Top Countries
Figure Australia Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure New Zealand Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure South America Subcutaneous Biologics Consumption and Growth Rate (2016-2021)
Figure South America Subcutaneous Biologics Revenue and Growth Rate (2016-2021)
Table South America Subcutaneous Biologics Sales Price Analysis (2016-2021)
Table South America Subcutaneous Biologics Consumption Volume by Types
Table South America Subcutaneous Biologics Consumption Structure by Application
Table South America Subcutaneous Biologics Consumption Volume by Major Countries
Figure Brazil Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Argentina Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Columbia Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Chile Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Venezuela Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Peru Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Puerto Rico Subcutaneous Biologics Consumption Volume from 2016 to 2021
Figure Ecuador Subcutaneous Biologics Consumption Volume from 2016 to 2021
Abbott Laboratories Subcutaneous Biologics Product Specification
Abbott Laboratories Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Pfizer Inc. Subcutaneous Biologics Product Specification
Pfizer Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Genentech Inc. Subcutaneous Biologics Product Specification
Genentech Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Novartis AG Subcutaneous Biologics Product Specification
Table Novartis AG Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Biogen Idec Subcutaneous Biologics Product Specification
Biogen Idec Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
AbbVie Inc. Subcutaneous Biologics Product Specification
AbbVie Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
F. Hoffmann-La Roche AG Subcutaneous Biologics Product Specification
F. Hoffmann-La Roche AG Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bristol-Myers Squibb Subcutaneous Biologics Product Specification
Bristol-Myers Squibb Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Eisai Inc. Subcutaneous Biologics Product Specification
Eisai Inc. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product Specification
Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Alnylam Pharmaceuticals Subcutaneous Biologics Product Specification
Alnylam Pharmaceuticals Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bayer AG Subcutaneous Biologics Product Specification
Bayer AG Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
GlaxoSmithKline Subcutaneous Biologics Product Specification
GlaxoSmithKline Subcutaneous Biologics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Figure Global Subcutaneous Biologics Consumption Volume and Growth Rate Forecast (2022-2027)
Figure Global Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Table Global Subcutaneous Biologics Consumption Volume Forecast by Regions (2022-2027)
Table Global Subcutaneous Biologics Value Forecast by Regions (2022-2027)
Figure North America Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure North America Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure United States Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure United States Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Canada Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Canada Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Mexico Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Mexico Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure East Asia Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure East Asia Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure China Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure China Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Japan Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Japan Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure South Korea Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure South Korea Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Europe Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Europe Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Germany Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Germany Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure UK Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure UK Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure France Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure France Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Italy Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Italy Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Russia Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Russia Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Spain Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Spain Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Netherlands Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Netherlands Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Swizerland Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Swizerland Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Poland Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Poland Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure South Asia Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure South Asia a Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure India Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure India Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Pakistan Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Pakistan Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Bangladesh Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Bangladesh Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Southeast Asia Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Southeast Asia Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Indonesia Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Indonesia Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Thailand Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Thailand Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Singapore Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Singapore Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Malaysia Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Malaysia Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Philippines Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Philippines Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Vietnam Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Vietnam Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Myanmar Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Myanmar Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Middle East Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Middle East Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Turkey Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Turkey Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Saudi Arabia Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Saudi Arabia Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Iran Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Iran Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure United Arab Emirates Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure United Arab Emirates Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Israel Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Israel Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Iraq Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Iraq Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Qatar Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Qatar Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Kuwait Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Kuwait Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Oman Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Oman Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Africa Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Africa Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Nigeria Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Nigeria Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure South Africa Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure South Africa Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Egypt Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Egypt Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Algeria Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Algeria Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Morocco Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Morocco Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Oceania Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Oceania Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Australia Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Australia Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure New Zealand Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure New Zealand Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure South America Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure South America Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Brazil Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Brazil Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Argentina Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Argentina Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Columbia Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Columbia Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Chile Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Chile Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Venezuela Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Venezuela Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Peru Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Peru Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Puerto Rico Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Puerto Rico Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Figure Ecuador Subcutaneous Biologics Consumption and Growth Rate Forecast (2022-2027)
Figure Ecuador Subcutaneous Biologics Value and Growth Rate Forecast (2022-2027)
Table Global Subcutaneous Biologics Consumption Forecast by Type (2022-2027)
Table Global Subcutaneous Biologics Revenue Forecast by Type (2022-2027)
Figure Global Subcutaneous Biologics Price Forecast by Type (2022-2027)
Table Global Subcutaneous Biologics Consumption Volume Forecast by Application (2022-2027)
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
